VGF | VGF nerve growth factor inducible | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ARRB1 | Arrestin, beta 1 | Predicted intracellular proteins
| | | | | Expressed in all |
DENND4C | DENN/MADD domain containing 4C | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
HNF1B | HNF1 homeobox B | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
RAB13 | RAB13, member RAS oncogene family | Predicted intracellular proteins
| | | | | Expressed in all |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
AP3S1 | Adaptor-related protein complex 3, sigma 1 subunit | Predicted intracellular proteins
| | | | | Expressed in all |
APRT | Adenine phosphoribosyltransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | Enzymes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 | FDA approved drug targets Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1C1 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1G1 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
BAIAP2L1 | BAI1-associated protein 2-like 1 | Predicted intracellular proteins
| | | | | Mixed |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CEP19 | Centrosomal protein 19kDa | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CHRM3 | Cholinergic receptor, muscarinic 3 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
CLOCK | Clock circadian regulator | Enzymes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
CPEB1 | Cytoplasmic polyadenylation element binding protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CPEB2 | Cytoplasmic polyadenylation element binding protein 2 | Predicted intracellular proteins
| | | | | Expressed in all |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CRY1 | Cryptochrome circadian clock 1 | Predicted intracellular proteins
| | | | | Expressed in all |
CRY2 | Cryptochrome circadian clock 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
EIF4B | Eukaryotic translation initiation factor 4B | Predicted intracellular proteins
| | | | | Expressed in all |
EIF4E | Eukaryotic translation initiation factor 4E | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
EIF4G1 | Eukaryotic translation initiation factor 4 gamma, 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
FGF5 | Fibroblast growth factor 5 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FOXA2 | Forkhead box A2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
GAD1 | Glutamate decarboxylase 1 (brain, 67kDa) | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
GLUL | Glutamate-ammonia ligase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
HADHA | Hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
HDAC5 | Histone deacetylase 5 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
HMGN3 | High mobility group nucleosomal binding domain 3 | Predicted intracellular proteins
| | | | | Expressed in all |
HTRA1 | HtrA serine peptidase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
HTT | Huntingtin | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
KANK1 | KN motif and ankyrin repeat domains 1 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
KCNC2 | Potassium voltage-gated channel, Shaw-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNG1 | Potassium voltage-gated channel, subfamily G, member 1 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
LPIN2 | Lipin 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
LYN | LYN proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |